PSY Therapeutics, Inc.
Boston, MA
- UEI
- HQN8CMYP15M3
- CAGE
- 8AZJ3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 28 Atlantic Ave #222, Boston, MA 02110, USA
- Website
- psythx.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of brain-penetrant comt inhibitors for the treatment of depressive disorders | National Institute of Mental Health (NIH) | $458,385 |
Quick answers
Is PSY Therapeutics, Inc. registered in SAM.gov?
Yes. PSY Therapeutics, Inc.'s SAM.gov registration is active through May 19, 2027.
What is PSY Therapeutics, Inc.'s most recent federal award?
PSY Therapeutics, Inc.'s most recent federal grant award is Development of brain-penetrant comt inhibitors for the treatment of depressive disorders (R43MH133470), from National Institute of Mental Health (NIH), on August 1, 2023.
On GovTribe
See PSY Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors